LEADER 05638nam 2201561z- 450 001 9910576872803321 005 20220621 035 $a(CKB)5720000000008448 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/84579 035 $a(oapen)doab84579 035 $a(EXLCZ)995720000000008448 100 $a20202206d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aUrological Cancer 2021 210 $cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (328 p.) 311 08$a3-0365-3048-7 311 08$a3-0365-3049-5 330 $aCancer of the urological sphere is a disease continuously increasing in numbers in the statistics of tumor malignancies in Western countries. Although this fact is mainly due to the contemporary increase of life expectancy of the people in these geographic areas, many other factors do contribute as well to this growth. Urological cancer is a complex and varied disease of different organs and mainly affects the male population. In fact, kidney, prostate, and bladder cancer are regularly included in the top-ten list of the most frequent neoplasms in males in most statistics. The female population, however, has also increasingly found itself affected by renal and bladder cancer in the last decade. Considering these altogether, urological cancer is a problem of major concern in developed societies. This Topic Issue of Cancers intends to shed some light into the complexity of this field and will consider all useful and appropriate contributions that scientists and clinicians may provide to improve urological cancer knowledge for patients' benefit. The precise identification of the molecular routes involved, the diagnostic pathological criteria in the grey zones, the dilemma of T1G3 management, and the possible treatment options between superficial, nonmuscle-invasive and muscle-invasive diseases will be particularly welcomed in this Issue. 606 $aChemistry$2bicssc 606 $aResearch & information: general$2bicssc 610 $a177Lu-PSMA 610 $aabiraterone 610 $aablation margins 610 $aadvanced urothelial carcinoma 610 $aAHNAK2 610 $aautopsy 610 $aBacillus Calmette-Gue?rin (BCG) 610 $abiomarker 610 $abiomarkers 610 $abiopsy 610 $abladder cancer 610 $abladder cancer cell lines 610 $abladder carcinoma 610 $acancer 610 $acell migration 610 $acomparative effectiveness 610 $acomparative oncology 610 $actDNA 610 $adecision making 610 $adiagnosis 610 $adivergent differentiation 610 $adocetaxel 610 $adog 610 $aenzalutamide 610 $aepiplakin 610 $aepithelial-mesenchymal transition 610 $afluorescence confocal microscopy 610 $afocal therapy 610 $afrail patients 610 $afrailty 610 $aFTY-720 610 $agame theory 610 $agenomic analysis 610 $agenomic signatures 610 $aglutaminase 610 $aHounsfield units 610 $aimage-guided 610 $aimmune checkpoint inhibitor 610 $aimmune checkpoint inhibitors 610 $aimmunohistochemistry 610 $aimmunotherapy 610 $ain situ methods 610 $ainflammation 610 $ainflammatory indices 610 $alatent cancer 610 $aliquid biopsy 610 $amachine learning 610 $amagnetic resonance imaging 610 $amCRPC 610 $ametastasectomy 610 $ametastasis 610 $ametastatic prostate cancer 610 $amicroenvironment 610 $amolecular subtypes 610 $amortality 610 $an/a 610 $anovel hormonal therapies 610 $aOIP5 610 $aoncological outcomes 610 $apapillary renal cell carcinoma 610 $aPD-1 610 $aPD-L1 610 $aPLK1 610 $apositron-emission tomography 610 $apostoperative complications 610 $apreclinical studies 610 $aprediction model 610 $apreneoplastic lesion 610 $aprognosis 610 $aprognostic 610 $aprognostic factor 610 $aprognostic index 610 $aprostate 610 $aprostate biopsy 610 $aprostate cancer 610 $aprostatic atrophy 610 $aprostatic neoplasms 610 $aPSA 610 $aPSMA-RLT 610 $apsoas muscle 610 $aradical cystectomy 610 $aradiosensitisation 610 $aradiotherapy 610 $areal-world treatment pattern 610 $arenal cell carcinoma 610 $ascreening trial 610 $asphingosine 1-phosphate receptor 1 610 $astereotactic body radiotherapy 610 $asurvival 610 $atherapy 610 $aTRIPOD 610 $atumor ecology 610 $atumor thrombus 610 $atumorigenesis 610 $atumour mutational board 610 $aultrasonography 610 $aurinary bladder neoplasms 610 $aurine 610 $aurothelial carcinoma 610 $avariant morphology 615 7$aChemistry 615 7$aResearch & information: general 702 $aManini$b Claudia 702 $aLo?pez$b Jose? I. 906 $aBOOK 912 $a9910576872803321 996 $aUrological Cancer 2021$93034948 997 $aUNINA